10/6/2022
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Aridis Announces the Closing of Patient Enrollment in the AR-301 Global Phase 3 Superiority Study

Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) announced that patient enrollment is closed in the AR-301 Phase 3 clinical study. The Company is on track to complete database lock, data analyses, and expects to disclose top-line data in December 2022. The AR-301-002 Phase 3 'ASAP-1' study compares the superiority of adjunctive use of the investigational, targeted immunotherapy candidate AR-301 with standard of care (SOC) antibiotics versus SOC antibiotics alone, for the treatment of ventilator associated pneumonia (VAP) caused by Gram-positive bacteria Staphylococcus aureus (S. aureus). Patients enrolled will complete their treatment and 28-day follow-up per study protocol.

Safety and efficacy of AR-301 are being evaluated using a randomized, double-blinded, placebo-controlled, superiority clinical trial design. The study was initiated as a globally harmonized Phase 3 study after the design and primary endpoint of clinical cure of pneumonia were reviewed by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

"Following the protracted COVID-19 pandemic that has slowed the pace of patient enrollment in clinical trials across the world, we are pleased to reach this key milestone for the study. We are working diligently to gather data from the clinical centers and report top-line results of this landmark Phase 3 study," said Aridis' Chief Medical Officer Hasan Jafri, MD.

For more information, visit www.aridispharma.com

 
See More Info
 
 
 

SciSparc Completes the Acquisition of Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million

SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced the closing of the definitive agreements for its acquisition of Wellution™, a top- seller Amazon.com Marketplace account, American food supplements and cosmetics brand and trademark. In connection with the Acquisition, the Company has incorporated a new wholly owned Delaware subsidiary, SciSparc Nutraceuticals Inc., to hold the new assets. The definitive agreement for the acquisition of the Brand was entered into with Merhavit M.R.M Holding and Management Ltd.

Wellution™ sells dozens of hemp-based, top-ranked products, including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.


 
Learn More
   

American Resources Corporation's ReElement Technologies Adds Battery Industry Veteran Bob Galyen to Advisory Board

American Resources Corporation (NASDAQ:AREC) , a next generation and socially responsible supplier of rare earth and critical elements, carbon and advanced carbon materials to the new infrastructure and electrification marketplace, announced that its majority-owned ReElement Technologies LLC division has added battery industry veteran and expert Bob Galyen to its advisory board.

Mark Jensen, CEO of American Resources Corporation commented, "We are honored and excited that Bob has agreed to join the ReElement advisory board at such an exciting moment for our Company. He brings a vast amount of experience to the Company in terms of battery manufacturing and recycling and will be extremely helpful in our ability to scale faster, better and stronger. Bob's time working with General Motors, Magna International, and CATL gives him tremendous breadth and depth of knowledge as well as industry relationships across all stages of the global battery supply chain.”

 
Learn More
 

EV Technology Group Announces Completion of Acquisition of Portfolio of Iconic Automotive Brands of Ford, Maserati and Ferrari Coach Builders

EV Technology Group Ltd. (NEO: EVTG, OTCQB: EVTGF, DE: B96A) announced that it has completed its acquisition of 1000310362 Ontario Inc. – also known as he Target -- previously announced by the Company on September 16, 2022. The Target holds a portfolio of intellectual property including iconic brands Officine Stampaggi Industriali, Fantuzzi, Marazzi and Brewster & Co.

EV Technology Group has a strategy of acquiring iconic, well loved automotive brands and then electrifying them for the future of motoring. This strategic Acquisition expands the portfolio of brands under EV Technology Group’s control and represents major potential to expand the future landscape of electric motoring. The brands in today’s Acquisition represent the epitome of world-class design and heritage, giving EV Technology Group the ability to leverage on existing brand value, and offer unique luxury EVs, with existing charm and heritage, to customers across the globe.

 
Learn More
 

Nemaura and EVERSANA Sign Preliminary Agreement for Large-Scale Launch of Nemaura’s Diabetes Management Program in the U.S.

Nemaura Medical, Inc.(NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced that it has entered into a preliminary agreement with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry.

The agreement covers the U.S. and all global sales and marketing of Nemaura’s Diabetes Management Solution, BEATdiabetes. The BEATdiabetes program is based on Nemaura’s noninvasive glucose monitoring solution, proBEAT. Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program, including franchising and direct sales to self-insured corporate clients and healthcare insurers.

 
Learn More
 

 
 

Upcoming Events

6
October
2022
NASDAQ: ARDS - Aridis Pharmaceuticals
4:15pm Eastern
Aridis Pharmaceuticals is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections.
 
Sign Up
 
12
October
2022
NASDAQ: SYTA - Siyata Mobile
4:15pm Eastern
Siyata Mobile (Siyata or the Company) is a leading developer and distributor of technologically advanced rugged smartphones, in-vehicle mounted IoT cellular communications devices, and cellular signal boosters for global first responders and enterprise customers based on Push-to-Talk Over Cellular (PoC) technology.
 
Sign Up
 
13
October
2022
NYSE American: DSS - DSS Inc.
4:15pm Eastern
DSS Inc. is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, securitized digital assets, securities trading and fund management, and banking, lending, and finance.
 
Sign Up
 
18
October
2022
NASDAQ: OKYO - OKYO Pharma Limited.
4:15pm Eastern
OKYO Pharma (OKYO) is a bio-pharmaceutical company focused on the discovery & development of first-in-class pharmaceutical therapies to treat inflammatory eye diseases including dry eye and ocular pain.
 
Sign Up
 
25
October
2022
OTCQB: QYOUF - QYOU Media Inc.
4:15pm Eastern
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators.
 
Sign Up
 
 
 

Archive Events

4
October
2022
OTCQB: OILCF - Permex Petroleum Corp
Meeting Duration 31 minutes
Permex Petroleum is a uniquely positioned junior Oil & Gas company with assets and operations across the Permian Basin of west Texas and the Delaware Sub-Basin of New Mexico.
 
Watch Replay
 
4
October
2022
OTC: EMOR - Healixa, Inc.
Meeting Duration 44 minutes
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries.
 
Watch Replay
 
3
October
2022
NASDAQ: HPCO - Hempacco Co., Inc.
Meeting Duration 22 minutes
Hempacco Co, Inc. is Disrupting Tobacco™ and its nearly $1 trillion industry by manufacturing and selling herb and hemp smokables from San Diego, California.
 
Watch Replay
 
28
September
2022
OTCQB: QYOUF - QYOU Media Inc.
Meeting Duration 44 minutes
One of the fastest growing creator-media companies, QYOU Media (OTCQB: QYOUF) operates in India and the United States producing, distributing, and monetizing content created by social media influencers and digital content stars.
 
Watch Replay
 
27
September
2022
NASDAQ: OKYO - OKYO Pharma Limited
Meeting Duration 34 minutes
OKYO Pharma (OKYO) is a bio-pharmaceutical company focused on the discovery & development of first-in-class pharmaceutical therapies to treat inflammatory eye diseases including dry eye and ocular pain.
 
Watch Replay
 
 
 

Lesson of the Week

Do your own homework when investing.

 
Learn More
 
 
 
All Videos
Full Episodes
 

RedChip TV

This Week on RedChip TV: Two Under-the-Radar Small-Cap Stocks

Genetic Technologies: The World Leader in Genetic Risk Assessments

Bragg Gaming: Targeting a $10 Billion Addressable U.S. Market

American Resources: Fast Growing Producer of Infrastructure Resources

QYOU Media: Significant and Growing Market Opportunity

 
 

MidSouth Week in Review

Mortgage rates surged to 6.9%, their highest level since 2007.

 
Learn More
 
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
© 2022 RedChip , All rights reserved